ProMIS Neurosciences (TSX:PMN) 3-Year EBITDA Growth Rate : -4.40% (As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is ProMIS Neurosciences 3-Year EBITDA Growth Rate?

ProMIS Neurosciences's EBITDA per Share for the three months ended in Dec. 2023 was C$-0.55.

During the past 3 years, the average EBITDA Per Share Growth Rate was -4.40% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 1.50% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 1.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of ProMIS Neurosciences was 34.00% per year. The lowest was -30.80% per year. And the median was 11.40% per year.

Competitive Comparison of ProMIS Neurosciences's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, ProMIS Neurosciences's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ProMIS Neurosciences's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ProMIS Neurosciences's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where ProMIS Neurosciences's 3-Year EBITDA Growth Rate falls into.

ProMIS Neurosciences 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

ProMIS Neurosciences (TSX:PMN) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

ProMIS Neurosciences 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of ProMIS Neurosciences's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

ProMIS Neurosciences (TSX:PMN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ProMIS Neurosciences Inc (TSX:PMN) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

PMN:USA 23J0:Germany

Address

1920 Yonge Street, Suite 200, Toronto, ON, CAN, M4S 3E2

Website

https://www.promisneurosciences.com

ProMIS Neurosciences Inc is focused on the discovery and development of precision medicine solutions for early detection and effective treatment of neurodegenerative diseases, including Alzheimer's disease, amyotrophic lateral sclerosis, and multiple system atrophy. The company also plans to investigate additional synucleionapathies, including Parkinson's disease, and dementia with Lewy bodies. It operates in Canada.